The list of compounds designated standard agents was originally determined by M.R. Boyd. He chose 171 drugs with cancer treatment New Drug Applications or Investigational New Drug Applications as well as compounds that had reached a particular high stage of interest at the
National Cancer Institute (NCI) in recent years for the list.
A Dataset of 171 unique molecules representing the standard agents.
Contains chemical structures, computed 3D geometries, and external identifiers.
Wolfram Research,
"NCI Standard Anticancer Agents"
from the Wolfram Data Repository
(2021)
License Information
"http://creativecommons.org/licenses/by-nc/3.0/", The data is under the "Creative Commons Attribution-NonCommercial License".
Data Resource History
Date Created:
Source Metadata
Title:
Status of the NCI preclinical antitumor drug discovery screen
Creator:
Michael R. Boyd
Publisher:
Lippincott
Date:
1989
Language:
English
Citation:
Boyd M.R., Status of the NCI preclinical antitumor drug discovery screen. In: DeVita V.T. Jr., Hellman S., Rosenberg S.A. (eds.), Cancer: Principles and Practice of Oncology Updates, vol. 3, no. 10. Philadelphia: Lippincott, 1–12, 1989.